Add BrightSurf on Google Email

Optimum protection against diabetes: Weight loss plus remission of prediabetes

Researchers found that people who achieved weight loss and prediabetes remission had a 76% lower risk of developing type 2 diabetes compared to those who only lost weight. This suggests that normalization of blood sugar levels should be included as a therapeutic goal in guidelines to improve diabetes prevention.

SourceDeutsches Zentrum fuer Diabetesforschung DZD·JournalDiabetologia·TypeObservational study·DateJun 27, 2024

Gene variant may underlie diabetes disparities: study

A genetic variation common in people of African ancestry is associated with an increased risk of diabetic retinopathy and nephropathy. Testing for this variant could help clinicians diagnose and treat diabetes more effectively, reducing disparities in diabetes complications between individuals of European and African ancestries.

SourceVanderbilt University Medical Center·JournalNature Medicine·DateJun 25, 2024

Study links gut microbiome changes to increased risk of type 2 diabetes

A large-scale study has found a consistent set of microbial species linked to type 2 diabetes across diverse populations. The researchers discovered that certain strains of bacteria have varied functions, including the ability to produce branched-chain amino acids, which may increase T2D risk.

SourceBrigham and Women's Hospital·JournalNature Medicine·DateJun 25, 2024
SAMSUNG T9 Portable SSD 2TB

SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.

Fight the late-night bright light

A Flinders University study found that exposure to brighter light at night is associated with a higher risk of developing type 2 diabetes. The research used data from approximately 85,000 people and tracked their light levels for nine years.

SourceFlinders University·JournalThe Lancet·TypeExperimental study·DateJun 24, 2024

Circulating microRNAs likely as effective as A1C for predicting type 2 diabetes in youth, according to OU study

A new study from the University of Oklahoma found that measuring circulating microRNAs is likely as effective as measuring blood sugar levels in determining how young people with type 2 diabetes will fare. The study also found a 20% decrease in beta cell function during the first six months of treatment.

SourceUniversity of Oklahoma·JournalThe Journal of Clinical Endocrinology and Metabolism·TypeData/statistical analysis·DateJun 24, 2024
Kestrel 3000 Pocket Weather Meter

Kestrel 3000 Pocket Weather Meter measures wind, temperature, and humidity in real time for site assessments, aviation checks, and safety briefings.

Study identifies first drug therapy for sleep apnea

Researchers have developed a novel drug therapy for obstructive sleep apnea (OSA), which has shown significant improvements in reducing breathing interruptions and improving overall health. The treatment targets both respiratory and metabolic complications, providing a promising alternative to existing therapies.

SourceUniversity of California - San Diego·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateJun 21, 2024

Paternal use of metformin during sperm production not associated with major birth defects

A study of almost 400,000 live births found that paternal use of metformin monotherapy was not significantly associated with major congenital malformations. However, researchers noted that fathers prescribed metformin had higher rates of cardiovascular and metabolic conditions, which could affect reproductive health.

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·TypeNews article·DateJun 17, 2024
Nikon Monarch 5 8x42 Binoculars

Nikon Monarch 5 8x42 Binoculars deliver bright, sharp views for wildlife surveys, eclipse chases, and quick star-field scans at dark sites.

Antipsychotic medications don’t just stop working below the neck

A potential new strategy for reducing diabetes risk associated with antipsychotic medications involves co-administering drugs that block dopamine receptors in the brain alongside those that stop these same receptors in the pancreas. This approach may limit metabolic side effects and improve glucose metabolism.

SourceUniversity of Pittsburgh·JournalDiabetes·DateJun 13, 2024

Social determinants of health linked with youth-onset prediabetes

A new study found that adolescents with higher rates of prediabetes often experience adverse social determinants of health, such as food insecurity and low household income. Screening for these non-medical factors may help identify youth at risk of progressing to type 2 diabetes.

SourceUniversity of Pittsburgh·JournalJAMA Network Open·DateJun 11, 2024

Passive heat exposure increases stress on the heart, posing risk to adults with history of CAD

A laboratory study found that passive heat exposure stresses the heart, increasing myocardial blood flow in all participants, regardless of age or health status. Adults with a history of CAD are at particular risk and may benefit from minimizing cardiac strain during extreme heat by staying cool.

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·TypeNews article·DateJun 10, 2024

New therapeutic targets to fight type 2 diabetes

A review article identifies new drug targets for treating type 2 diabetes, including growth differentiation factor (GDF15) and TGF-β pathways. Metformin's mechanism of action is also reevaluated, revealing a novel pathway of inhibiting mitochondrial complex IV.

SourceUniversity of Barcelona·JournalTrends in Endocrinology & Metabolism·TypeExperimental study·DateJun 7, 2024
GoPro HERO13 Black

GoPro HERO13 Black records stabilized 5.3K video for instrument deployments, field notes, and outreach, even in harsh weather and underwater conditions.

Research shows GLP-1 receptor agonist drugs are effective but come with complex concerns

Research shows that GLP-1 receptor agonist drugs are highly effective for weight management and Type 2 diabetes treatment, but they come with complex considerations such as dosages, side effects, and comparisons between specific drugs. Experts caution against overusing these drugs or viewing them as a universal cure-all for obesity.

SourceUniversity of Chicago Medical Center·JournalHealth Affairs Scholar·DateJun 5, 2024
Sony Alpha a7 IV (Body Only)

Sony Alpha a7 IV (Body Only) delivers reliable low-light performance and rugged build for astrophotography, lab documentation, and field expeditions.

Genetic link between diabetes and gut health could offer treatment solutions

Researchers at Edith Cowan University have found a significant genetic connection between Type 2 Diabetes and certain gut disorders, which could lead to more effective therapies. The study uncovered shared biological origins with Type 2 Diabetes among gut conditions like stomach ulcers and irritable bowel syndrome.

SourceEdith Cowan University·JournalCommunications Biology·TypeMeta-analysis·DateMay 28, 2024

Semaglutide significantly reduces risk of major kidney disease events, cardiovascular outcomes and mortality in patients with type 2 diabetes and chronic kidney disease, groundbreaking study reveals

A groundbreaking study reveals semaglutide significantly reduces the risk of major kidney disease events, cardiovascular outcomes, and all-cause mortality in patients with type 2 diabetes and chronic kidney disease. Semaglutide also shows improved safety and efficacy profiles.

SourceBeyond·JournalNew England Journal of Medicine·DateMay 24, 2024
Rigol DP832 Triple-Output Bench Power Supply

Rigol DP832 Triple-Output Bench Power Supply powers sensors, microcontrollers, and test circuits with programmable rails and stable outputs.

New study further illuminates ability of cancer drug to lower blood sugar

A new study reveals that a cancer drug can improve insulin sensitivity and lower blood glucose levels, but eliminating a specific gene related to fat metabolism worsens insulin resistance. The research highlights the interconnectedness of fat metabolism in organs and the need for simultaneous treatment of obesity and insulin sensitivity.

SourceUniversity of Oklahoma·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateMay 23, 2024

Young people are increasingly using Wegovy and Ozempic

A national study found a significant increase in the use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) among adolescents and young adults in the US. Female adolescents showed a higher increase in GLP-1RA usage compared to males, highlighting the need for education on potential safety risks during pregnancy.

SourceMichigan Medicine - University of Michigan·JournalJAMA·DateMay 22, 2024
AmScope B120C-5M Compound Microscope

AmScope B120C-5M Compound Microscope supports teaching labs and QA checks with LED illumination, mechanical stage, and included 5MP camera.

Study with innovative insights into the heterogeneity of type 2 diabetes

Researchers developed an algorithm to stratify people with type 2 diabetes using routine data, revealing metabolic diversity and insulin sensitivity variability. The study's findings have the potential to change the way we understand and treat type 2 diabetes.

SourceDeutsches Zentrum fuer Diabetesforschung DZD·JournalThe Lancet Diabetes & Endocrinology·TypeData/statistical analysis·DateMay 13, 2024

Semaglutide can produce clinically meaningful weight loss and reduce waist size for at least 4 years in adults with overweight or obesity who don’t have diabetes, and delivers cardiovascular benefits irrespective of weight lost

Two studies based on the SELECT trial show semaglutide leads to sustained weight loss of 10% body weight and 7cm waist reduction after 4 years, regardless of starting weight or BMI. The medication also delivers cardiovascular benefits, with a lower risk of heart attack, stroke, or death.

SourceEuropean Association for the Study of Obesity·JournalNature Medicine·DateMay 13, 2024

Kallistatin contributes to the beneficial metabolic effects of weight loss

Researchers found that Kallistatin expression increases after weight loss in individuals with overweight and obesity. Additionally, human Kallistatin improves hepatic insulin sensitivity in diet-induced obese mice. The study suggests that Kallistatin may be an interesting therapeutic target for people with obesity and type 2 diabetes.

SourceDeutsches Zentrum fuer Diabetesforschung DZD·JournalMolecular Metabolism·TypeExperimental study·DateMay 13, 2024

Do sex differences in how adipose tissue responds to insulin explain why type 2 diabetes is more common in men?

Researchers found that men with obesity have increased adipose tissue insulin resistance and higher levels of free fatty acids in the blood. This may partly explain why type 2 diabetes is more common in men. The study suggests that sex differences in adipose tissue insulin sensitivity could be a key factor in this disparity.

SourceEuropean Association for the Study of Obesity·JournalInternational Journal of Obesity·DateMay 10, 2024
Apple iPhone 17 Pro

Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.

New NIH grant aims to combat sight damage from diabetes

A new NIH grant will investigate biological processes that contribute to defects in immune response in the eyes of those with diabetes. Researchers aim to understand why diabetic patients are more susceptible to corneal infections and identify methods to reverse these effects.

SourceWayne State University - Office of the Vice President for Research·DateMay 7, 2024

New drug candidate reverses obesity in mice

Researchers at Karolinska Institutet have discovered a new class of drugs that block mitochondrial function and reverse diet-induced obesity, fatty liver, and diabetes in mice. The treatment increased fat metabolism, leading to drastic weight loss and restored glucose tolerance.

SourceKarolinska Institutet·JournalNature Metabolism·TypeExperimental study·DateApr 30, 2024

Physical activity in nature helps prevent several diseases, including depression and type 2 diabetes

Research from the University of Exeter found that physical activity in natural environments can prevent six non-communicable diseases, including depression and type 2 diabetes. The study estimated that nature-based physical activity prevented 12,763 cases of disease in England annually, saving £108.7m in healthcare costs.

SourceUniversity of Exeter·JournalEnvironment International·DateApr 25, 2024

Food in sight? The liver is ready!

Researchers at Max Planck Institute discover that liver mitochondria adapt to food presence via nerve cells, leading to improved insulin sensitivity. This finding could pave the way for new type 2 diabetes treatments.

SourceMax Planck Institute for Biology of Ageing·JournalScience·TypeExperimental study·DateApr 25, 2024
CalDigit TS4 Thunderbolt 4 Dock

CalDigit TS4 Thunderbolt 4 Dock simplifies serious desks with 18 ports for high-speed storage, monitors, and instruments across Mac and PC setups.

Artificial sweetener has potential to damage gut

Neotame has been shown to cause previously healthy gut bacteria to become diseased and invade the gut wall, potentially leading to irritable bowel syndrome and sepsis. The study also found a breakdown of the epithelial barrier, which forms part of the gut wall.

SourceAnglia Ruskin University·JournalFrontiers in Nutrition·DateApr 24, 2024

The consumption of certain food additive emulsifiers could be associated with the risk of developing type 2 diabetes

A large French study found a link between chronic exposure to certain emulsifiers and increased risk of developing type 2 diabetes. The researchers analyzed data from over 104,000 adults and observed an association with several emulsifiers.

SourceINRAE - National Research Institute for Agriculture, Food and Environment·JournalThe Lancet Diabetes & Endocrinology·DateApr 23, 2024

Genetics predict type 2 diabetes risk and disparities in childhood cancer survivors

Researchers identified four genetic variants associated with increased type 2 diabetes risk in childhood cancer survivors. The findings also showed that polygenic risk scores derived from diverse ancestry datasets were more informative in assessing diabetes risk in survivors of both European and African ancestries, highlighting the imp...

SourceSt. Jude Children's Research Hospital·JournalJournal of Clinical Oncology·TypeObservational study·DateApr 23, 2024

ACP issues clinical recommendations for newer diabetes treatments

The American College of Physicians recommends adding SGLT-2 and GLP-1 agonists to metformin in adults with Type 2 diabetes for improved cardiovascular outcomes. The guidelines prioritize shared decision-making, considering individual patient characteristics and values.

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·TypeNews article·DateApr 19, 2024

This outdated diabetes drug still has something to offer

Scientists at University of California San Diego discover how one TZD drug works and replicate its benefits in mice without side effects. Researchers identify specific microRNA responsible for beneficial metabolic effects, paving the way for potential new therapies for type 2 diabetes.

SourceUniversity of California - San Diego·JournalNature Metabolism·DateApr 11, 2024
Meta Quest 3 512GB

Meta Quest 3 512GB enables immersive mission planning, terrain rehearsal, and interactive STEM demos with high-resolution mixed-reality experiences.

CMS121 mitigates aging-related obesity and metabolic dysfunction

Researchers found that CMS121 reduced body weight gain by 40% and improved glucose and lipid indexes in aging mice. The compound also showed anti-inflammatory effects and increased mitochondrial biogenesis, suggesting potential therapeutic applications for metabolic diseases.

SourceImpact Journals LLC·JournalAging-US·TypeExperimental study·DateApr 9, 2024

Childhood sedentariness causes excessive insulin, raising the risk of type 2 diabetes

A new study found that increased childhood sedentary time is associated with higher blood insulin concentration and a greater risk of excess insulin and insulin resistance. Light physical activity was shown to reduce the risk of excess insulin by 20%, while moderate-to-vigorous physical activity had a smaller effect.

SourceUniversity of Eastern Finland·JournalThe Journal of Clinical Endocrinology and Metabolism·DateApr 9, 2024
Aranet4 Home CO2 Monitor

Aranet4 Home CO2 Monitor tracks ventilation quality in labs, classrooms, and conference rooms with long battery life and clear e-ink readouts.

Few newly diagnosed type 2 diabetics succeed in losing weight – weight gain linked to much higher risk of complications

A Finnish study found that only 10% of newly diagnosed type 2 diabetics lost weight, while 3% gained weight, highlighting the challenges of achieving weight loss in these patients. The study also showed a strong association between weight gain and increased risk of microvascular and macrovascular complications.

SourceUniversity of Eastern Finland·JournalClinical Epidemiology·DateApr 4, 2024
Apple iPad Pro 11-inch (M4)

Apple iPad Pro 11-inch (M4) runs demanding GIS, imaging, and annotation workflows on the go for surveys, briefings, and lab notebooks.

Clear shift in arterial diseases in diabetes

Studies at the University of Gothenburg found a clear shift in arterial disease risks in diabetes, with decreases in central organ diseases like heart attack and stroke, but increases in peripheral vessel complications. Closer monitoring of long-term blood sugar levels can reduce peripheral arterial disease risk by 30-50%.

SourceUniversity of Gothenburg·JournalThe Lancet Regional Health - Europe·TypeObservational study·DateMar 28, 2024

Do sweeteners increase your appetite? New evidence from randomised controlled trial says no

A new study has found that replacing sugar with artificial and natural sweeteners in foods does not make people hungrier, but may help reduce blood sugar levels. The trial involved 53 adult men and women with overweight or obesity and found no differences in appetite or endocrine responses compared to sugar.

SourceUniversity of Leeds·JournalEBioMedicine·TypeRandomized controlled/clinical trial·DateMar 28, 2024
Creality K1 Max 3D Printer

Creality K1 Max 3D Printer rapidly prototypes brackets, adapters, and fixtures for instruments and classroom demonstrations at large build volume.

Comparative study of type 2 diabetes medications show differences in medication acceptance, quality-of-life, insulin secretion and mortality

A comparative study of four major type 2 diabetes medications reveals differences in medication acceptance, quality of life, insulin secretion, and mortality. The GRADE Study found that younger age and higher blood sugar levels at baseline were associated with poor blood sugar control over time.

SourcePennington Biomedical Research Center·JournalDiabetes Care·DateMar 25, 2024

Astonishing conformity: Gompertz law predicts mortality in type 2 diabetes

Researchers used the Gompertz model to predict mortality rates in people with type 2 diabetes, achieving values of over 97% accuracy in their predictions. The study found that mortality rates increase exponentially with age and are higher in females due to lower life expectancy.

SourceDeutsches Zentrum fuer Diabetesforschung DZD·JournalActa Diabetologica·TypeData/statistical analysis·DateMar 21, 2024
Davis Instruments Vantage Pro2 Weather Station

Davis Instruments Vantage Pro2 Weather Station offers research-grade local weather data for networked stations, campuses, and community observatories.

NTU Singapore scientists invent a coin-sized device to rapidly isolate blood plasma for diagnostics and precision medicine

Researchers at NTU Singapore have created a chip that can directly isolate blood plasma from a tube of blood in just 30 minutes, removing over 99.9% of blood cells and platelets. The device, called ExoArc, enables high-quality plasma for disease screening and research, improving diagnosis accuracy and reducing waiting times.

SourceNanyang Technological University·JournalACS Nano·TypeRandomized controlled/clinical trial·DateMar 21, 2024